Integrative transcriptomic profiling of a mouse model of hypertension-accelerated diabetic kidney disease

被引:4
|
作者
Sembach, Frederikke E. [1 ]
AEgidius, Helene M. [1 ]
Fink, Lisbeth N. [1 ]
Secher, Thomas [1 ]
Aarup, Annemarie [1 ]
Jelsing, Jacob [1 ]
Vrang, Niels [1 ]
Feldt-Rasmussen, Bo [2 ,3 ]
Rigbolt, Kristoffer T. G. [1 ]
Nielsen, Jens C. [1 ]
Ostergaard, Mette V. [1 ]
机构
[1] Gubra ApS, Horsholm Kongevej 11B, DK-2970 Horsholm, Denmark
[2] Univ Copenhagen, Dept Clin Med, Blegdamsvej 3B, DK-2200 Copenhagen, Denmark
[3] Univ Copenhagen, Dept Nephrol, Rigshosp, Blegdamsvej 9, DK-2100 Copenhagen, Denmark
关键词
Diabetic kidney disease; Mouse model; Laser-capture microdissection; Single-nucleus; Glomerulus; RNAseq; INFLAMMATION; EXPRESSION; NEPHROPATHY; PROGRESSION; MECHANISMS; BIOMARKERS; FIBROSIS; OUTCOMES; PATHWAY;
D O I
10.1242/dmm.049086
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The current understanding of molecular mechanisms driving diabetic kidney disease (DKD) is limited, partly due to the complex structure of the kidney. To identify genes and signalling pathways involved in the progression of DKD, we compared kidney cortical versus glomerular transcriptome profiles in uninephrectomized (UNx) db/db mouse models of early-stage (UNx only) and advanced [UNxplus adeno-associated virus-mediated renin-1 overexpression (UNx-Renin)] DKD using RNAseq. Compared to normoglycemic db/m mice, db/db UNx and db/db UNx-Renin mice showed marked changes in their kidney cortical and glomerular gene expression profiles. UNx-Renin mice displayed more marked perturbations in gene components associated with the activation of the immune system and enhanced extracellular matrix remodelling, supporting histological hallmarks of progressive DKD in this model. Single-nucleus RNAseq enabled the linking of transcriptome profiles to specific kidney cell types. In conclusion, integration of RNAseq at the cortical, glomerular and single-nucleus level provides an enhanced resolution of molecular signalling pathways associated with disease progression in preclinical models of DKD, and may thus be advantageous for identifying novel therapeutic targets in DKD.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] UPLC-MS-based urine nontargeted metabolic profiling identifies dysregulation of pantothenate and CoA biosynthesis pathway in diabetic kidney disease
    Ma, Tao
    Liu, Tonghua
    Xie, Peifeng
    Jiang, Sheng
    Yi, Wenming
    Dai, Pei
    Guo, Xiangyu
    LIFE SCIENCES, 2020, 258
  • [42] A renaissance in the treatment of diabetic kidney disease, hypertension in chronic kidney disease, and beyond
    Yahr, Jordana
    Calle, Juan
    Taliercio, Jonathan J.
    JOURNAL OF OSTEOPATHIC MEDICINE, 2021, 122 (01): : 55 - 63
  • [43] In-depth urinary and exosome proteome profiling analysis identifies novel biomarkers for diabetic kidney disease
    Du, Shichun
    Zhai, Linhui
    Ye, Shu
    Wang, Le
    Liu, Muyin
    Tan, Minjia
    SCIENCE CHINA-LIFE SCIENCES, 2023, 66 (11) : 2587 - 2603
  • [44] Ficolin B in Diabetic Kidney Disease in a Mouse Model of Type 1 Diabetes
    Holt, Charlotte Berg
    Ostergaard, Jakob Appel
    Axelgaard, Esben
    Nielsen, Gitte Krogh
    Endo, Yuichi
    Thiel, Steffen
    Hansen, Troels Krarup
    MEDIATORS OF INFLAMMATION, 2015, 2015
  • [45] C-reactive protein promotes diabetic kidney disease in a mouse model of type 1 diabetes
    F. Liu
    H. Y. Chen
    X. R. Huang
    A. C. K. Chung
    L. Zhou
    P. Fu
    A. J. Szalai
    H. Y. Lan
    Diabetologia, 2011, 54 : 2713 - 2723
  • [46] New mouse model of chronic kidney disease transitioned from ischemic acute kidney injury
    Wei, Jin
    Zhang, Jie
    Wang, Lei
    Jiang, Shan
    Fu, Liying
    Buggs, Jacentha
    Liu, Ruisheng
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2019, 317 (02) : F286 - F295
  • [47] Development and internal validation of a risk model for hyperuricemia in diabetic kidney disease patients
    Huang, Guoqing
    Li, Mingcai
    Mao, Yushan
    Li, Yan
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [48] Establishment of a potent weighted risk model for determining the progression of diabetic kidney disease
    Zhang, Tianxiao
    Wang, Xiaodan
    Zhang, Yueying
    Yang, Ying
    Yang, Congying
    Wei, Huiyi
    Zhao, Qingbin
    JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21 (01)
  • [49] Metformin improves relevant disease parameters in an autosomal dominant polycystic kidney disease mouse model
    Pastor-Soler, Nuria M.
    Li, Hui
    Pham, Jessica
    Rivera, Daniel
    Ho, Pei-Yin
    Mancino, Valeria
    Saitta, Biagio
    Hallows, Kenneth R.
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2022, 322 (01) : F27 - F41
  • [50] Dapagliflozin reverses the imbalance of T helper 17 and T regulatory cells by inhibiting SGK1 in a mouse model of diabetic kidney disease
    Wang, Dan
    Zhang, Zikun
    Si, Zekun
    Yang, Yanlin
    Li, Shuangshuang
    Xue, Yaoming
    FEBS OPEN BIO, 2021, 11 (05): : 1395 - 1405